Stimulant dependence including amphetamines, methamphetamine or methcathinone (Q40426): Difference between revisions

From determinar.ia.br - Determine suas informações
Changed an Item
Changed an Item
 
(One intermediate revision by the same user not shown)
Property / Collection date
 
13 August 2026
Timestamp+2026-08-13T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / Collection date: 13 August 2026 / rank
 
Normal rank
Property / Linked ICD 10
 
Property / Linked ICD 10: F15.2 / rank
 
Normal rank

Latest revision as of 06:13, 13 August 2026

Stimulant dependence including amphetamines, methamphetamine or methcathinone but excluding cocaine and synthetic cathinones is a disorder of regulation of stimulant use arising from repeated or continuous use of stimulants. The characteristic feature is a strong internal drive to use stimulants, which is manifested by impaired ability to control use, increasing priority given to use over other activities and persistence of use despite harm or negative consequences. These experiences are often accompanied by a subjective sensation of urge or craving to use stimulants. Physiological features of dependence may also be present, including tolerance to the effects of stimulants, withdrawal symptoms following cessation or reduction in use of stimulants, or repeated use of stimulants or pharmacologically similar substances to prevent or alleviate withdrawal symptoms. The features of dependence are usually evident over a period of at least 12 months but the diagnosis may be made if stimulant use is continuous (daily or almost daily) for at least 3 months.
Language Label Description Also known as
default for all languages
6C46.2
    English
    Stimulant dependence including amphetamines, methamphetamine or methcathinone
    Stimulant dependence including amphetamines, methamphetamine or methcathinone but excluding cocaine and synthetic cathinones is a disorder of regulation of stimulant use arising from repeated or continuous use of stimulants. The characteristic feature is a strong internal drive to use stimulants, which is manifested by impaired ability to control use, increasing priority given to use over other activities and persistence of use despite harm or negative consequences. These experiences are often accompanied by a subjective sensation of urge or craving to use stimulants. Physiological features of dependence may also be present, including tolerance to the effects of stimulants, withdrawal symptoms following cessation or reduction in use of stimulants, or repeated use of stimulants or pharmacologically similar substances to prevent or alleviate withdrawal symptoms. The features of dependence are usually evident over a period of at least 12 months but the diagnosis may be made if stimulant use is continuous (daily or almost daily) for at least 3 months.

      Statements

      CID11:6C46.2
      0 references
      dki-india-6C46.2
      0 references
      Concluído
      0 references
      13 August 2026
      0 references
      0 references